An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group

Objective. The importance of contextual factors (CF) for appropriate patient-specific care is widely acknowledged. However, evidence in clinical trials on how CF influence outcomes remains sparse. The 2014 Outcome Measures in Rheumatology (OMERACT) Handbook introduced the role of CF in outcome assessment and defined them as “potential confounders and/or effect modifiers of outcomes in randomized controlled trials.” Subsequently, the CF Methods Group (CFMG) was formed to develop guidance on how to address CF in clinical trials. Methods. First, the CFMG conducted an e-mail survey of OMERACT working groups (WG) to analyze how they had addressed CF in outcome measurement so far. The results facilitated an informed discussion at the OMERACT 2016 CFMG Special Interest Group (SIG) session, with the aim of gaining preliminary consensus regarding an operational definition of CF and to make a first selection of potentially relevant CF. Results. The survey revealed that the WG had mostly used the OMERACT Handbook and/or the International Classification of Functioning, Disability and Health (ICF) definition. However, significant heterogeneity was found in the methods used to identify, refine, and categorize CF candidates. The SIG participants agreed on using the ICF as a framework along with the OMERACT Handbook definition. A list with 28 variables was collected including person-related factors and physical and social environments. Recommendations from the SIG guided the CFMG to formulate 3 preliminary projects on how to identify and analyze CF. Conclusion. New methods are urgently needed to assist researchers to identify and characterize CF that significantly influence the interpretation of results in clinical trials. The CFMG defined first steps to develop further guidance.

[1]  Eva Petkova,et al.  Generated effect modifiers (GEM's) in randomized clinical trials. , 2017, Biostatistics.

[2]  T. Smith,et al.  Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials , 2016, Annals of the rheumatic diseases.

[3]  Debbie Johnson,et al.  What matters to children with CFS/ME? A conceptual model as the first stage in developing a PROM , 2015, Archives of Disease in Childhood.

[4]  Thais Pousada García,et al.  Exploring the Psychosocial Impact of Wheelchair and Contextual Factors on Quality of Life of People with Neuromuscular Disorders , 2015, Assistive technology : the official journal of RESNA.

[5]  D. Furst,et al.  Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study , 2015, PloS one.

[6]  What Challenges Manual Workers’ Ability to Cope with Back Pain at Work, and What Influences Their Decision to Call in Sick? , 2015, Journal of Occupational Rehabilitation.

[7]  D. Morisky,et al.  Assessment of Rheumatoid Arthritis Patients' Adherence to Treatment , 2015, The American journal of the medical sciences.

[8]  A. Boonen,et al.  Understanding Limitations in At-work Productivity in Patients with Active Ankylosing Spondylitis: The Role of Work-related Contextual Factors , 2015, The Journal of Rheumatology.

[9]  Lisa J. Martin,et al.  Food , drug , insect sting allergy , and anaphylaxis Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis , 2022 .

[10]  D. M. van der Heijde,et al.  The ASAS Health Index (ASAS HI) - a new tool to assess the health status of patients with spondyloarthritis. , 2014, Clinical and experimental rheumatology.

[11]  P. Tugwell,et al.  Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. , 2014, Journal of clinical epidemiology.

[12]  P. Tugwell,et al.  How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0 , 2014, The Journal of Rheumatology.

[13]  A. Orbai,et al.  Establishing a Core Domain Set to Measure Rheumatoid Arthritis Flares: Report of the OMERACT 11 RA Flare Workshop , 2014, The Journal of Rheumatology.

[14]  D. M. van der Heijde,et al.  Report from the OMERACT Hand Osteoarthritis Special Interest Group: Advances and Future Research Priorities , 2014, The Journal of Rheumatology.

[15]  P. Merkel,et al.  Current Status of Outcome Measure Development in Vasculitis , 2014, The Journal of Rheumatology.

[16]  Elizabeth A. Stormshak,et al.  Putting theory to the test: Examining family context, caregiver motivation, and conflict in the Family Check-Up model , 2014, Development and Psychopathology.

[17]  P. Tugwell,et al.  Including Health Equity Considerations in Development of Instruments for Rheumatology Research: An Introduction to a Novel OMERACT Paradigm , 2014, The Journal of Rheumatology.

[18]  P. Tugwell,et al.  Worker Productivity Outcome Measures: OMERACT Filter Evidence and Agenda for Future Research , 2014, The Journal of Rheumatology.

[19]  Diane Hauser,et al.  Context Matters: The Experience of 14 Research Teams in Systematically Reporting Contextual Factors Important for Practice Change , 2013, The Annals of Family Medicine.

[20]  Richard D Riley,et al.  Prognosis research strategy (PROGRESS) 4: Stratified medicine research , 2013, BMJ : British Medical Journal.

[21]  Ethan M Balk,et al.  Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials , 2012, Annals of Internal Medicine.

[22]  J. Stanghelle,et al.  Efficacy of rehabilitation for patients with ankylosing spondylitis: comparison of a four-week rehabilitation programme in a Mediterranean and a Norwegian setting. , 2011, Journal of rehabilitation medicine.

[23]  P. Pronovost,et al.  How does context affect interventions to improve patient safety? An assessment of evidence from studies of five patient safety practices and proposals for research , 2011, Quality and Safety in Health Care.

[24]  Stephen D. Persell,et al.  Contextual Errors and Failures in Individualizing Patient Care , 2010, Annals of Internal Medicine.

[25]  D. M. van der Heijde,et al.  Asas/who Icf Core Sets for Ankylosing Spondylitis (as): How to Classify the Impact of as on Functioning and Health Extended Report , 2022 .

[26]  K. Emmons,et al.  Model for incorporating social context in health behavior interventions: applications for cancer prevention for working-class, multiethnic populations. , 2003, Preventive medicine.

[27]  M. T. J. Buñuales,et al.  La clasificación internacional del funcionamiento de la discapacidad y de la salud (CIF) 2001 , 2002 .